Brinzolamide

AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
Do not take if: AZOPT is contraindicated in patients who are hypersensitive to any component of this product.

Who should not take it

AZOPT is contraindicated in patients who are hypersensitive to any component of this product.

2 dosage and administration

The recommended dose is one drop of AZOPT in the affected eye(s) 3 times daily. Shake well before use. AZOPT may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 10 minutes apart.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Brinzolamide; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/brinzolamide
APA 7th: sofidex. (2026, August 2). Brinzolamide. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/brinzolamide
AMA 11th: Brinzolamide. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/brinzolamide

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.